Future Proofing Adverse Event Monitoring John D. Seeger Commentary 01 September 2015 Pages: 847 - 848
Product-Specific Regulatory Pathways to Approve Generic Drugs: The Need for Follow-up Studies to Ensure Safety and Effectiveness Aaron S. KesselheimJoshua J. Gagne Current Opinion 24 June 2015 Pages: 849 - 853
Pharmacogenetics of Drug-Induced QT Interval Prolongation: An Update Maartje N. NiemeijerMarten E. van den BergBruno H. Stricker Review Article Open access 25 June 2015 Pages: 855 - 867
Safety Profile of Certolizumab Pegol in Patients with Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-Analysis Alice Capogrosso SansoneStefania MantarroCorrado Blandizzi Systematic Review 28 August 2015 Pages: 869 - 888
Photosensitivity with Angiotensin II Receptor Blockers: A Retrospective Study Using Data from VigiBase® Ermelinda ViolaAnna Coggiola PittoniAnita Conforti Short Communication 18 July 2015 Pages: 889 - 894
A Method to Combine Signals from Spontaneous Reporting Systems and Observational Healthcare Data to Detect Adverse Drug Reactions Ying LiPatrick B. RyanCarol Friedman Original Research Article Open access 08 July 2015 Pages: 895 - 908
Benzodiazepine Use and Risk of Developing Alzheimer’s Disease or Vascular Dementia: A Case–Control Analysis Patrick ImfeldMichael BodmerChristoph R. Meier Original Research Article 30 June 2015 Pages: 909 - 919
Evaluating Social Media Networks in Medicines Safety Surveillance: Two Case Studies Preciosa M. ColomaBenedikt BeckerJan A. Kors Original Research Article Open access 05 August 2015 Pages: 921 - 930
Comment on: “Adverse Drug Reactions and Clinical Outcomes in Patients Initiated on Antiretroviral Therapy: A Prospective Cohort Study from Ethiopia” Mark CottonSimone Nicol Letter to the Editor 05 August 2015 Pages: 931 - 931
Authors’ Reply to Cotton and Nicol’s Comment on “Adverse Drug Reactions and Clinical Outcomes in Patients Initiated on Antiretroviral Therapy: A Prospective Cohort Study from Ethiopia” Woldesellassie M. BezabheLuke R. BereznickiGregory M. Peterson Letter to the Editor 05 August 2015 Pages: 933 - 933
15th ISoP Annual Meeting “Cubism in Pharmacovigilance” Prague, Czech Republic 27-30 October, 2015 Abstracts 15 September 2015 Pages: 935 - 1048